June 13, 2008 | Vol. 2 No. 24
After learning that a transport trailer carrying 9,000 vials of high-value injectable medications was stolen while in transit in Tennessee, Johnson & Johnson (J&J) recalled several lots of the drugs associated with the shipment.
A Maryland-based contract manufacturer entered a consent decree with the FDA for distributing unapproved prescription cough syrups containing hydrocodone that were manufactured under conditions that did not meet GMPs.
Elge, an OTC private label contract manufacturer, received a warning letter for inappropriate use of U.S. Pharmacopeia (USP) tests to identify incoming active pharmaceutical ingredients (APIs) for its cough and allergy products.
Leiner Health Products will be sold to NBTY for $371 million, according to documents filed Tuesday with the U.S. Securities Exchange Commission.
Generic drug company Mylan Inc. is cutting jobs at a plant in central Puerto Rico.
Patheon Inc., a global provider of drug development and manufacturing services to the international pharmaceutical industry, announced it will expand the Manati, Puerto Rico facility to add a dedicated high potency and controlled substance manufacturing area.
Researchers are reporting preliminary success with a vaccine against a possible "bird flu" pandemic, using a process they say could deliver the product in half the time required by older technology.
Although Internet drug purchasing is known to be a dicey proposition, the extent of the risk has never been established.
To help medical device manufacturers stay ahead of tightening environmental restrictions on the use of toxic lead, PolyOne Corporation … developed Trilliant HC PbF compounds as lead-free alternatives for radiation shielding.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.